We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,756 hedge funds and large institutions have $252B invested in Johnson & Johnson in 2019 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 1,129 increasing their positions, 1,289 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 66

4.93% more ownership

Funds ownership: 68.05%72.98% (+4.9%)

0% less funds holding

Funds holding: 2,7662,756 (-10)

0% less capital invested

Capital invested by funds: $253B → $252B (-$1.14B)

7% less funds holding in top 10

Funds holding in top 10: 690639 (-51)

11% less call options, than puts

Call options by funds: $1.69B | Put options by funds: $1.9B

12% less repeat investments, than reductions

Existing positions increased: 1,129 | Existing positions reduced: 1,289

Holders
2,756
Holders Change
-10
Holders Change %
-0.36%
% of All Funds
59.85%
Holding in Top 10
639
Holding in Top 10 Change
-51
Holding in Top 10 Change %
-7.39%
% of All Funds
13.88%
New
91
Increased
1,129
Reduced
1,289
Closed
66
Calls
$1.69B
Puts
$1.9B
Net Calls
-$208M
Net Calls Change
+$260M
Name Holding Trade Value Shares
Change
Change in
Stake
FIM
326
Foresters Investment Management
New York
$43.7M -$2.63M -18,992 -6%
EWM
327
Evercore Wealth Management
New York
$43.6M +$916K +6,614 +2%
CI
328
Cambiar Investors
Colorado
$42.9M -$3.04M -21,980 -7%
AIM
329
Artemis Investment Management
United Kingdom
$42.8M +$18.9M +136,439 +79%
WBC
330
Westpac Banking Corp
Australia
$42.7M +$4.51M +32,589 +12%
PCA
331
Personal Capital Advisors
California
$42.6M +$2.29M +16,555 +6%
Northwestern Mutual Wealth Management
332
Northwestern Mutual Wealth Management
Wisconsin
$42.6M -$1.39M -10,072 -3%
SF
333
Synovus Financial
Georgia
$42.4M +$200K +1,447 +0.5%
AIM
334
Achmea Investment Management
Netherlands
$42.3M +$729K +5,269 +2%
DP
335
Dearborn Partners
Illinois
$42.2M +$975K +7,041 +2%
NLI
336
Nippon Life Insurance
Japan
$42.2M
CSIC
337
Clifford Swan Investment Counsel
California
$41.6M -$611K -4,411 -1%
CBOA
338
Commonwealth Bank of Australia
Australia
$41.2M -$15.7M -113,367 -28%
SMDAM
339
Sumitomo Mitsui DS Asset Management
Japan
$40.4M -$1.08M -7,830 -3%
AII
340
AGF Investments Inc
Ontario, Canada
$40.4M -$2.77K -20 -0%
CCMG
341
Clark Capital Management Group
Pennsylvania
$39.6M +$1.33M +9,606 +3%
WSFS
342
Wilmington Savings Fund Society
Delaware
$39.6M -$663K -4,791 -2%
FP
343
Foundry Partners
Minnesota
$39.3M +$2.67M +19,269 +7%
ORIO
344
Old Republic International (ORI)
Illinois
$39.2M
CDH
345
Charles D. Hyman
$39M +$110K +792 +0.3%
AIMCA
346
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$39M +$5.44M +39,300 +16%
SIA
347
Sit Investment Associates
Minnesota
$38.9M +$200K +1,445 +0.5%
VDI
348
Vaughan David Investments
Illinois
$38.9M -$64.5K -466 -0.2%
B
349
BP
United Kingdom
$38.7M
SAM
350
Securian Asset Management
Minnesota
$38.7M +$214K +1,548 +0.6%

JNJ Hedge Fund Activity: Q2 2019 in Review

2,756 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2019, worth a combined $252B — down 0.45% from $253B a quarter earlier.

Buyers outnumbered sellers: 91 funds opened new JNJ positions and 66 closed out — a net gain of 25 holders — while 1,129 added to existing stakes and 1,289 trimmed.

The largest buyer was Phocas Financial Corp, adding an estimated $17.3B. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $719M.

  • 2,756 institutional investors held Johnson & Johnson (JNJ) as of Q2 2019, down from 2,766 in Q1 2019.
  • Funds reported $252B of Johnson & Johnson stock for Q2 2019, down 0.45% quarter-over-quarter.
  • 91 funds opened new Johnson & Johnson positions in Q2 2019 and 66 closed out, a net change of +25 holders.
  • The largest Johnson & Johnson buyer in Q2 2019 was Phocas Financial Corp, an estimated $17.3B added.
  • The largest Johnson & Johnson seller in Q2 2019 was Barrow, Hanley, Mewhinney & Strauss, an estimated $719M sold.

Based on aggregated 13F filings for Q2 2019.